Intervention

Psilocybin 5 mg

ClinicalTrials.gov intervention label

Clinical trials2

Recruiting0

Common conditions3

Lead sponsors shown2

Clinical trials

2 shown

Psilocybin Therapy for Methamphetamine Use Disorder and HIVNCT07756736 · 2026-11-01

NOT_YET_RECRUITING

Psilocybin for Major Depressive Disorder (MDD)NCT06308653 · 2024-03-13

ACTIVE_NOT_RECRUITING

Common conditions

Depressive Disorder, Major1 Human Immunodeficiency Virus (HIV)1 Methamphetamine Use Disorder1

Leading sponsors

Nicky Mehtani, MD, MPH1 Usona Institute1

Trial status mix

ACTIVE_NOT_RECRUITING1

NOT_YET_RECRUITING1

Phase mix

PHASE21

PHASE31

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.